Michael Briggs

Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment

L. Ranganath, Anna M. Milan, Andrew T. Hughes et al. · Annals of the Rheumatic Diseases · 2014 · 157 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +6

Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial

L. Ranganath, Eftychia Eirini Psarelli, Jean-Baptiste Arnoux et al. · The Lancet Diabetes & Endocrinology · 2020 · 123 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +3

The National Kidney Disease Education Program: Improving Understanding, Detection, and Management of CKD

Andrew S. Narva, Michael Briggs · American Journal of Kidney Diseases · 2009 · 53 citations

Medicine, Health Education, Nephrology +12

Prevalence of Estimated GFR Reporting Among US Clinical Laboratories

Nancy A. Accetta, Elisa H. Gladstone, Charles DiSogra et al. · American Journal of Kidney Diseases · 2008 · 43 citations · Full text

Medicine, Health Sciences, Internal Medicine +6

Adult bacterial conjunctivitis: resistance patterns over 12 years in patients attending a large primary eye care centre in the UK

Alexander Silvester, Timothy Neal, Gabriela Czanner et al. · BMJ Open Ophthalmology · 2016 · 27 citations · Full text

Medicine, Microbiology, Ophthalmology +17